215 related articles for article (PubMed ID: 34123844)
1. IP-10 (CXCL10) Can Trigger Emergence of Dormant Breast Cancer Cells in a Metastatic Liver Microenvironment.
Clark AM; Heusey HL; Griffith LG; Lauffenburger DA; Wells A
Front Oncol; 2021; 11():676135. PubMed ID: 34123844
[TBL] [Abstract][Full Text] [Related]
2. A Model of Dormant-Emergent Metastatic Breast Cancer Progression Enabling Exploration of Biomarker Signatures.
Clark AM; Kumar MP; Wheeler SE; Young CL; Venkataramanan R; Stolz DB; Griffith LG; Lauffenburger DA; Wells A
Mol Cell Proteomics; 2018 Apr; 17(4):619-630. PubMed ID: 29353230
[TBL] [Abstract][Full Text] [Related]
3. Modeling the Complexity of the Metastatic Niche Ex Vivo.
Clark AM
Methods Mol Biol; 2021; 2258():221-239. PubMed ID: 33340364
[TBL] [Abstract][Full Text] [Related]
4. Statins attenuate outgrowth of breast cancer metastases.
Beckwitt CH; Clark AM; Ma B; Whaley D; Oltvai ZN; Wells A
Br J Cancer; 2018 Oct; 119(9):1094-1105. PubMed ID: 30401978
[TBL] [Abstract][Full Text] [Related]
5. An in vitro system to study tumor dormancy and the switch to metastatic growth.
Barkan D; Green JE
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21860375
[TBL] [Abstract][Full Text] [Related]
6. A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.
Soejima K; Rollins BJ
J Immunol; 2001 Dec; 167(11):6576-82. PubMed ID: 11714827
[TBL] [Abstract][Full Text] [Related]
7. Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition.
Taylor DP; Clark A; Wheeler S; Wells A
Breast Cancer Res Treat; 2014 Apr; 144(3):551-60. PubMed ID: 24610032
[TBL] [Abstract][Full Text] [Related]
8. A liver microphysiological system of tumor cell dormancy and inflammatory responsiveness is affected by scaffold properties.
Clark AM; Wheeler SE; Young CL; Stockdale L; Shepard Neiman J; Zhao W; Stolz DB; Venkataramanan R; Lauffenburger D; Griffith L; Wells A
Lab Chip; 2016 Dec; 17(1):156-168. PubMed ID: 27910972
[TBL] [Abstract][Full Text] [Related]
9. An in vitro hyaluronic acid hydrogel based platform to model dormancy in brain metastatic breast cancer cells.
Narkhede AA; Crenshaw JH; Crossman DK; Shevde LA; Rao SS
Acta Biomater; 2020 Apr; 107():65-77. PubMed ID: 32119920
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton.
Barkan D; Kleinman H; Simmons JL; Asmussen H; Kamaraju AK; Hoenorhoff MJ; Liu ZY; Costes SV; Cho EH; Lockett S; Khanna C; Chambers AF; Green JE
Cancer Res; 2008 Aug; 68(15):6241-50. PubMed ID: 18676848
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
Tamamouna V; Pavlou E; Neophytou CM; Papageorgis P; Costeas P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430404
[TBL] [Abstract][Full Text] [Related]
12. Autophagy in breast cancer metastatic dormancy: Tumor suppressing or tumor promoting functions?
Flynn AB; Schiemann WP
J Cancer Metastasis Treat; 2019; 5():. PubMed ID: 31431926
[TBL] [Abstract][Full Text] [Related]
13. Autophagy and Hepatic Tumor Microenvironment Associated Dormancy.
Akkoc Y; Gozuacik D
J Gastrointest Cancer; 2021 Dec; 52(4):1277-1293. PubMed ID: 34921672
[TBL] [Abstract][Full Text] [Related]
14. Modeling the breast cancer bone metastatic niche in complex three-dimensional cocultures.
Marlow R; Dontu G
Methods Mol Biol; 2015; 1293():213-20. PubMed ID: 26040690
[TBL] [Abstract][Full Text] [Related]
15. The osteoblast in regulation of tumor cell dormancy and bone metastasis.
Zarrer J; Taipaleenmäki H
J Bone Oncol; 2024 Apr; 45():100597. PubMed ID: 38550395
[TBL] [Abstract][Full Text] [Related]
16. Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.
Marsden CG; Wright MJ; Carrier L; Moroz K; Rowan BG
PLoS One; 2012; 7(11):e47587. PubMed ID: 23173031
[TBL] [Abstract][Full Text] [Related]
17. Gene expression predicts dormant metastatic breast cancer cell phenotype.
Ren Q; Khoo WH; Corr AP; Phan TG; Croucher PI; Stewart SA
Breast Cancer Res; 2022 Jan; 24(1):10. PubMed ID: 35093137
[TBL] [Abstract][Full Text] [Related]
18. The Role of the Innate Immune System in Cancer Dormancy and Relapse.
Chernosky NM; Tamagno I
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830776
[TBL] [Abstract][Full Text] [Related]
19.
Montagner M; Sahai E
Front Cell Dev Biol; 2020; 8():37. PubMed ID: 32195244
[TBL] [Abstract][Full Text] [Related]
20. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
